Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid versus sublingual misoprostol for women undergoing primary abdominal myomectomy
PACTR202502529024955Not yet recruiting
- Sponsor
- Esan Babatunde Ayodeji
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tranexamic acid and misoprostol in Fibromyoma (LM) (2 arms), sponsored by Esan Babatunde Ayodeji. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tranexamic acidmisoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202502529024955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502529024955.